Amyloid Neuropathies, Familial
"Amyloid Neuropathies, Familial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inherited disorders of the peripheral nervous system associated with the deposition of AMYLOID in nerve tissue. The different clinical types based on symptoms correspond to the presence of a variety of mutations in several different proteins including transthyretin (PREALBUMIN); APOLIPOPROTEIN A-I; and GELSOLIN.
| Descriptor ID |
D028227
|
| MeSH Number(s) |
C10.574.500.050 C10.668.829.050.050 C16.320.400.050 C16.320.565.176.050 C18.452.648.176.050 C18.452.845.500.050.050 C18.452.845.500.075.050
|
| Concept/Terms |
Amyloid Neuropathies, Familial- Amyloid Neuropathies, Familial
- Amyloid Neuropathy, Familial
- Familial Amyloid Neuropathies
- Familial Amyloid Neuropathy
- Neuropathies, Familial Amyloid
- Neuropathy, Familial Amyloid
- Hereditary Neuropathic Amyloidosis
- Amyloidoses, Hereditary Neuropathic
- Amyloidosis, Hereditary Neuropathic
- Hereditary Neuropathic Amyloidoses
- Neuropathic Amyloidoses, Hereditary
- Neuropathic Amyloidosis, Hereditary
- Familial Amyloid Polyneuropathies
- Amyloid Polyneuropathies, Familial
- Amyloid Polyneuropathy, Familial
- Familial Amyloid Polyneuropathy
- Polyneuropathies, Familial Amyloid
- Polyneuropathy, Familial Amyloid
Amyloid Polyneuropathy, British Type- Amyloid Polyneuropathy, British Type
- Type III Familial Amyloid Polyneuropathy
- Familial Amyloid Polyneuropathy, Type III
- Iowa Type Amyloid Polyneuropathy
- Amyloid Polyneuropathy, Iowa Type
- British Type Amyloid Polyneuropathy
Familial Amyloid Neuropathy, Portuguese Type- Familial Amyloid Neuropathy, Portuguese Type
- Familial Amyloid Neuropathy, Andrade Type
- Familial Amyloid Polyneuropathy, Type I
- Familial Portuguese Polyneuritic Amyloidosis
- Wohlwill-Corino Andrade Syndrome
- Syndrome, Wohlwill-Corino Andrade
- Wohlwill Corino Andrade Syndrome
- Polyneuritic Amyloidosis, Portuguese
- Amyloidoses, Portuguese Polyneuritic
- Amyloidosis, Portuguese Polyneuritic
- Polyneuritic Amyloidoses, Portuguese
- Portuguese Polyneuritic Amyloidoses
- Portuguese Polyneuritic Amyloidosis
- Portuguese Type Familial Amyloid Neuropathy
- Type I Familial Amyloid Polyneuropathy
- Wohlwill-Andrade Syndrome
- Syndrome, Wohlwill-Andrade
- Wohlwill Andrade Syndrome
- Amyloid Neuropathy Type 1
- Neuropathic Amyloid Syndrome
- Amyloid Syndrome, Neuropathic
- Amyloid Syndromes, Neuropathic
- Neuropathic Amyloid Syndromes
- Syndrome, Neuropathic Amyloid
- Syndromes, Neuropathic Amyloid
Familial Amyloid Polyneuropathy, Type V- Familial Amyloid Polyneuropathy, Type V
- Finnish Type Familial Amyloid Neuropathy
- Type V Familial Amyloid Polyneuropathy
- Familial Amyloid Neuropathy, Finnish Type
Amyloid Polyneuropathy, Swiss Type- Amyloid Polyneuropathy, Swiss Type
- Swiss Type Amyloid Polyneuropathy
- Type II Familial Amyloid Polyneuropathy
- Familial Amyloid Polyneuropathy, Type II
|
Below are MeSH descriptors whose meaning is more general than "Amyloid Neuropathies, Familial".
- Diseases [C]
- Nervous System Diseases [C10]
- Neurodegenerative Diseases [C10.574]
- Heredodegenerative Disorders, Nervous System [C10.574.500]
- Amyloid Neuropathies, Familial [C10.574.500.050]
- Neuromuscular Diseases [C10.668]
- Peripheral Nervous System Diseases [C10.668.829]
- Amyloid Neuropathies [C10.668.829.050]
- Amyloid Neuropathies, Familial [C10.668.829.050.050]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Heredodegenerative Disorders, Nervous System [C16.320.400]
- Amyloid Neuropathies, Familial [C16.320.400.050]
- Metabolism, Inborn Errors [C16.320.565]
- Amyloidosis, Familial [C16.320.565.176]
- Amyloid Neuropathies, Familial [C16.320.565.176.050]
- Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
- Metabolism, Inborn Errors [C18.452.648]
- Amyloidosis, Familial [C18.452.648.176]
- Amyloid Neuropathies, Familial [C18.452.648.176.050]
- Proteostasis Deficiencies [C18.452.845]
- Amyloidosis [C18.452.845.500]
- Amyloid Neuropathies [C18.452.845.500.050]
- Amyloid Neuropathies, Familial [C18.452.845.500.050.050]
- Amyloidosis, Familial [C18.452.845.500.075]
- Amyloid Neuropathies, Familial [C18.452.845.500.075.050]
Below are MeSH descriptors whose meaning is more specific than "Amyloid Neuropathies, Familial".
This graph shows the total number of publications written about "Amyloid Neuropathies, Familial" by people in this website by year, and whether "Amyloid Neuropathies, Familial" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 1 | 3 |
| 2016 | 2 | 0 | 2 |
| 2017 | 4 | 0 | 4 |
| 2018 | 1 | 1 | 2 |
| 2019 | 2 | 0 | 2 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amyloid Neuropathies, Familial" by people in Profiles.
-
ATTR Epidemiology, Genetics, and Prognostic Factors. Methodist Debakey Cardiovasc J. 2022; 18(2):17-26.
-
Wild-Type Transthyretin Cardiac Amyloidosis Is Associated with Increased Antecedent Physical Activity. J Cardiovasc Transl Res. 2022 08; 15(4):689-691.
-
Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT. ESC Heart Fail. 2021 10; 8(5):3875-3884.
-
Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study. Eur J Heart Fail. 2021 02; 23(2):277-285.
-
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR). Cardiovasc Drugs Ther. 2020 06; 34(3):357-370.
-
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid?Cardiomyopathy. J Am Coll Cardiol. 2019 07 23; 74(3):285-295.
-
Positive family history decreases diagnosis time by over 200. Amyloid. 2019; 26(sup1):17.
-
Seven factors predict a delayed diagnosis of cardiac amyloidosis. Amyloid. 2018 Sep; 25(3):174-179.
-
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018 Sep 13; 379(11):1007-1016.
-
Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years. Amyloid. 2017 Sep; 24(3):194-204.